Jeff Slezak to Disease-Free Survival
This is a "connection" page, showing publications Jeff Slezak has written about Disease-Free Survival.
Connection Strength
0.245
-
Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Perm J. 2019; 23.
Score: 0.041
-
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007 Apr; 82(4):422-7.
Score: 0.018
-
Long-term success of antegrade endopyelotomy compared with pyeloplasty at a single institution. J Endourol. 2006 Oct; 20(10):707-12.
Score: 0.017
-
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
Score: 0.017
-
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
Score: 0.016
-
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005 Apr; 95(6):751-6.
Score: 0.016
-
Surgical treatment for local control of female urethral carcinoma. Urol Oncol. 2004 Sep-Oct; 22(5):404-9.
Score: 0.015
-
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003 Nov; 170(5):1872-6.
Score: 0.014
-
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer. 2002 Aug; 34(4):363-71.
Score: 0.013
-
Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol. 2002 Jan; 167(1):117-22.
Score: 0.013
-
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 2001 Jun; 57(6):1033-7.
Score: 0.012
-
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc. 2001 Jun; 76(6):576-81.
Score: 0.012
-
Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999 Nov 01; 86(9):1775-82.
Score: 0.011
-
Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999 Mar; 161(3):857-62; discussion 862-3.
Score: 0.010
-
Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998 Dec; 22(12):1491-500.
Score: 0.010
-
Preoperative androgen-deprivation therapy for clinical stage T3 prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):222-9.
Score: 0.009